ELSA

FDA’s New AI Tool Struggles with Basic Tasks

The U.S. Food and Drug Administration (FDA) is already encountering implementation issues with its efforts to leverage the potential benefits of AI-based technologies.

FDA to Expand Use of AI in Scientific Reviews

The use of artificial intelligence (AI) tools is rapidly gaining traction throughout industries around the world. Now, the U.S. Food and Drug Administration (FDA) is stepping up to leverage the potential benefits of AI.

Digital Sponsors

Become a Sponsor

What's New

EMC Bench Notes: Interpreting Emissions Using a Near-Field Probe

FDA Releases Guidance Document on Human Factors Information in Marketing Submissions

FDA Updates List of Recognized Consensus Standards

Choosing the Right Oscilloscope for Compliance Testing: A Practical Guide

FCC Approves New Source for Verifying E911 Location Accuracy

- From Our Sponsors -